Alastair Hay, PhD, Account Manager – Peptides at Almac, explains how the company is advancing human health through innovation and investment in the field of individualized cancer vaccines.   Background At Almac we first became aware of the field of individualized cancer vaccines when we were asked, “Do you thi ...

James Lawler, Head of Quality at C2 PHARMA, explains how the implementation of virtual manufacturing strategies can ensure supply chain security and the reliable delivery of high-quality therapeutic products.   Guaranteeing the supply of medicines is absolutely essential for ensuring patient health and wellbeing. Sh ...

We speak to Dr Fritjof Weidner, Market Manager Advanced Intermediates at Biesterfeld Spezialchemie, about the transformation effect of organic synthesis on drug discovery, and how the science is driving demand for organic intermediates and products for pharmaceuticals.   Organic chemistry – the study of carbon-co ...